Upperton Pharma Solutions, has been shortlisted in two major categories at the Pharma Industry Awards UK 2025:
- Pharma Industry Company of the Year
- Pharma Contract Services Company of the Year
The awards celebrate excellence and innovation across the UK pharmaceutical and biopharmaceutical sectors with finalists rigorously selected by an independent panel of experts from academia and industry. This double nomination recognises Upperton’s continued growth, scientific leadership, and strong track record in supporting drug development and manufacturing across oral, nasal and pulmonary dosage forms.
The winners will be announced at the awards ceremony on 10 September 2025, taking place at the Park Plaza London Riverbank.
This year’s nominations follow Upperton’s success at the 2024 Pharma Industry Awards, where we were proud to win Large Pharma Project of the Year for the build of our 50,000 sq. ft development and manufacturing facility, Trent Gateway. That recognition marked a milestone in our development as a leading CDMO partner for biotech and pharmaceutical companies and this year’s shortlisting builds on that momentum.
Now in its third year, the Pharma Industry Awards UK, organised by BusinessRiver, recognises outstanding achievements across the pharmaceutical ecosystem, from researchers and CDMOs to formulation engineers, supply chain experts and marketing teams.
The awards honour excellence in innovation, strategy, collaboration, and measurable impact on healthcare and patient outcomes.
Get in touch.
If you’re looking to work with a CDMO that can support your product from preclinical development to market and beyond, then we’re here to help.
